Delivery Order SPE2DB24D1205-SPE2DB25FCYPM
- Not listed
- This federal contract award is for the delivery of 1,000 capsules of the prescription medication Tamsulosin Hydrochloride 0.4 mg. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The total ceiling value of the contract is $4,995.20, and it is structured as a firm fixed-price delivery order. The contract has an ultimate completion date of April 24, 2024. Amerisourcebergen holds a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,000 units of the drug Tamsulosin HCL 0.4 mg capsules. The contract has a firm fixed price of $1,636.98 and an ultimate completion date of May 13, 2024. The contract is a Delivery Order and was awarded on May 10, 2024 with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $65,411.87 to provide 4,564,298,844 capsules of Tamsulosin HCL 0.4 mg. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 17, 2024. The contract is a firm fixed-price arrangement, without any set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. This...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,610,559 capsules of Tamsulosin HCl 0.4 mg. The contract has a completion date of February 12, 2024 and a potential value of $2,459.44. This award is under a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a maximum potential value of $999,999,999.00 through December 31,...
- This federal contract award, valued at $2,879.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of the medication Tamsulosin HCL 0.4 mg capsules, with a performance period extending to April 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award is a delivery order valued at $1,443.94, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 1,000 units of the prescription medication Tamsulosin HCL 0.4 mg capsules, with a performance period ending on May 15, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and no subcontractors...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,703.94, is a delivery order for the supply of 1,000 capsules of the medication Tamsulosin Hydrochloride 0.4 mg. The contract is a firm fixed-price agreement with a completion date of May 14, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set aside for any...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1,000 capsules of Tamsulosin HCl 0.4 mg. The $5,622.40 award is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide pharmaceutical products and medical supplies to support Department of Defense military treatment facilities...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order with a Firm Fixed Price valued at $1,954.40. The contract was awarded by the Defense Logistics Agency (DLA) to provide 4,566,179,279 units of the drug Tamsulosin Hydrochloride 0.4 mg Capsule with an ultimate completion date of October 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which...
- This federal contract award, valued at $2,353.29, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a delivery order, is for the supply of Tamsulosin HCl 0.4 mg capsules and has a firm fixed price. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCYPMDelivery Order
The federal contract award is for the delivery of 1,000 capsules of the pharmaceutical drug Tamsulosin HCl 0.4 mg. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The award has a ceiling value of $2,631.63 and is a firm fixed-price delivery order with a completion date of July 16, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military and other government healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 7/15/25 |